☆ 4.3 Review

Canadian Digestive Health Foundation Public Impact Series 3: Irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

期刊

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

卷 26, 期 5, 页码 252-256

出版社

HINDAWI LTD

DOI: 10.1155/2012/861478

关键词

Burden of disease; Canada; Chronic disease; Digestive disease; Epidemiology; Irritable bowel syndrome

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

Reagent

摘要

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning irritable bowel syndrome.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Psychology, Clinical

Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study

Rei Monden, Judith G. M. Rosmalen, Klaas J. Wardenaar, Francis Creed

Summary: This prospective population-based study assessed the predictors of new onsets of irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS), and fibromyalgia (FM). The study found that syndrome-specific predictors were more common than shared ones. The study also revealed a close relationship between IBS and FM, which requires further research.

PSYCHOLOGICAL MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms

L. Queneherve, D. Drui, J. Blin, M. Pere, E. Coron, G. Barbara, M. R. Barbaro, B. Cariou, M. Neunlist, D. Masson, K. Bach-Ngohou

Summary: Gastrointestinal symptoms are common in patients with chronic adrenal insufficiency, with a significant impact on quality of life. A considerable proportion of these patients meet the criteria for irritable bowel syndrome, and their overall quality of life is often described as poor or very poor.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019

Yichen Wang, Yuting Huang, Robert C. Chase, Tian Li, Daryl Ramai, Si Li, Xiaoquan Huang, Samuel O. Antwi, Andrew P. Keaveny, Maoyin Pang

Summary: This study examined the worldwide burden of digestive diseases from 1990 to 2019. The incidence and prevalence of digestive diseases remained relatively stable during this period, with enteric infections being the primary cause. There was a significant disparity in the burden of digestive diseases among countries with different development levels.

GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population

Colleen H. Parker, Bruce D. Naliboff, Wendy Shih, Angela P. Presson, Lisa Kilpatrick, Arpana Gupta, Cathy Liu, Laurie A. Keefer, Jenny S. Sauk, Robert Hirten, Bruce E. Sands, Lin Chang

Summary: The study found that resilience is lower in patients with Irritable Bowel Syndrome (IBS) compared to the general population, leading to more severe symptoms. The impact of global mental health on resilience is more significant in IBS compared to the general population, and early adverse life events also decrease the ability to bounce back from adversity. While resilience in IBS is lower than the general US population, it is comparable to other chronic gastrointestinal conditions.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan

Yu-Tung Lai, Chung-Yu Chen, Ming-Jong Bair

Summary: The study revealed a decreasing trend in the incidence and prevalence of IBS in Taiwan from 2012 to 2018, with over 70% of patients receiving treatment and antispasmodics being the most commonly prescribed medication. However, only 48.58% of patients returned for a follow-up visit within 1 year of IBS diagnosis.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Irritable bowel syndrome in China: a review on the epidemiology, diagnosis, and management

Yi-Lin Liu, Jin-Song Liu

Summary: IBS is a common gastrointestinal disease globally, with current guidelines mainly based on western populations. China, with its large population, has a vast literature on IBS, but linguistic variations have caused these studies to be less known in western medical literature. Research on IBS in the Chinese population can benefit understanding and future studies in this area.

CHINESE MEDICAL JOURNAL (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Post COVID-19 irritable bowel syndrome

Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Egidia Miftode, Pietro Fusaroli, Salem Youssef Mohamed, Chiara Ricci, Massimo Bellini, Mohammed Masudur Rahman, Luigi Melcarne, Javier Santos, Beatriz Lobo, Serhat Bor, Suna Yapali, Deniz Akyol, Ferdane Pirincci Sapmaz, Yonca Yilmaz Urun, Tugce Eskazan, Altay Celebi, Huseyin Kacmaz, Berat Ebik, Hatice Cilem Binicier, Mehmet Sait Bugdayci, Munkhtsetseg Banzragch Yagci, Husnu Pullukcu, Berrin Yalinbas Kaya, Ali Tureyen, Ibrahim Hatemi, Elif Sitre Koc, Goktug Sirin, Ali Riza Caliskan, Goksel Bengi, Esra Ergun Alis, Snezana Lukic, Meri Trajkovska, Keren Hod, Dan Dumitrascu, Antonello Pietrangelo, Elena Corradini, Magnus Simren, Jessica Sjoelund, Navkiran Tornkvist, Uday C. Ghoshal, Olga Kolokolnikova, Antonio Colecchia, Jordi Serra, Giovanni Maconi, Roberto De Giorgio, Silvio Danese, Piero Portincasa, Antonio Di Sabatino, Marcello Maggio, Elena Philippou, Yeong Yeh Lee, Daniele Salvi, Alessandro Venturi, Claudio Borghi, Marco Zoli, Paolo Gionchetti, Pierluigi Viale, Vincenzo Stanghellini, Giovanni Barbara

Summary: This study aimed to evaluate the prevalence of gastrointestinal symptoms and post-COVID-19 disorders of gut-brain interaction among hospitalized patients with SARS-CoV-2 infection. The results showed that patients with COVID-19 had higher rates of gastrointestinal symptoms on hospital admission and lower rates of constipation and hard stools at 12 months post-infection compared to the control group. Additionally, the rate of irritable bowel syndrome was significantly higher in patients with COVID-19 than in controls.

GUT (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review

Marilyn Hagan, Bu' Hussain Hayee, Ana Rodriguez-Mateos

Summary: Polyphenols (PPs) may have therapeutic benefits in gastrointestinal (GI) disorders like IBS or IBD, but the evidence base is inconsistent and further research is needed to clarify their effects.

MOLECULES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

The Rising Burden of Inflammatory Bowel Disease in Denmark Over Two Decades: A Nationwide Cohort Study

Manasi Agrawal, Heidi S. Christensen, Martin Bogsted, Jean-Frederic Colombel, Tine Jess, Kristine H. Allin

Summary: The incidence and prevalence of IBD have increased in Denmark over the past two decades, and the IBD population is shifting towards an older age.

GASTROENTEROLOGY (2022)

添加到收藏夹

Article Neurosciences

Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study

Tuomas H. Mertsalmi, Anna But, Eero Pekkonen, Filip Scheperjans

Summary: A retrospective study indicates that patients with irritable bowel syndrome (IBS) have an increased risk of developing Parkinson's disease (PD) in the first two years, but not in the long term. The findings suggest that IBS may be a prodromal symptom of PD rather than an actual risk factor.

JOURNAL OF PARKINSONS DISEASE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

Michael Camilleri, Guy Boeckxstaens

Summary: This article evaluates the evidence that targeted pathophysiological mechanisms and customized treatments can be an alternative approach to treating patients with irritable bowel syndrome (IBS). The authors conducted a literature review on the mechanisms and treatments of IBS, identifying various noninvasive clinical tests that can assess the underlying mechanisms responsible for symptom generation. These mechanisms include rectal evacuation disorders, abnormal transit, visceral hypersensitivity or hypervigilance, bile acid diarrhea, sugar intolerances, barrier dysfunction, the microbiome, immune activation, and chemicals released by these mechanisms. The authors also recognized the basic molecular mechanisms contributing to these pathophysiologies, offering opportunities for interventions with medications targeted at specific food components, receptors, and potentially the microbiome. Although the evidence supporting interventions for each mechanism varies, the current state-of-the-art allows for a shift from symptom-based treatment to individualized treatment guided by pathophysiology and clinically identified biomarkers.

GUT (2023)

添加到收藏夹

Article Nutrition & Dietetics

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD

Martyna Wiecek, Paulina Panufnik, Magdalena Kaniewska, Konrad Lewandowski, Grazyna Rydzewska

Summary: The study found that in patients in remission of IBD, a low-FODMAP diet intervention is effective in reducing IBS-like symptoms, regardless of the presence of bacterial overgrowth.

NUTRIENTS (2022)

添加到收藏夹

Article Dermatology

Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome: A large-scale global study

Khalaf Kridin, Ralf J. Ludwig

Summary: Isotretinoin does not increase the risk of Crohn's disease, but it may be associated with a slight and temporary increase in the risk of ulcerative colitis. However, it can lower the risk of irritable bowel syndrome.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

添加到收藏夹

Review Medicine, General & Internal

Irritable Bowel Syndrome and Resilience

Mihaela Fadgyas Stanculete, Abdulrahman Ismaiel, Stefan-Lucian Popa, Octavia Oana Capatina

Summary: Irritable bowel syndrome (IBS) is a disorder characterized by altered gut-brain interaction and dysfunction of the brain-gut-microbiota axis. Prior studies have shown significant impairments in the health-related quality of life of patients with IBS. Resilience, as a psychosocial ability, plays a crucial role in promoting health and enhancing stress response.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database

Zahid Ijaz Tarar, Umer Farooq, Ahmad Nawaz, Mustafa Gandhi, Yezaz A. Ghouri, Asmeen Bhatt, Brooks D. Cash

Summary: The study found a significant correlation between IBS and fibromyalgia and chronic fatigue syndrome (CFS), with higher prevalence rates in IBS patients compared to the general adult population without IBS. Different subtypes of IBS, age, gender, and race were identified as predictors for increased odds of fibromyalgia and CFS.

BIOMEDICINES (2023)

添加到收藏夹

Editorial Material Medicine, General & Internal

A 29-year-old woman with Crohn disease considering pregnancy

Vivian Huang, Richard Fedorak

CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal Microbial Transplant After Ileocolic Resection Reduces Ileitis but Restores Colitis in IL-10-/- Mice

Troy Perry, Juan Jovel, Jordan Patterson, Gane Wong, Richard N. Fedorak, Aducio Thiesen, Bryan Dicken, Karen L. Madsen

INFLAMMATORY BOWEL DISEASES (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response

Christopher Ma, Vivian Huang, Darryl K. Fedorak, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak

JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

Edward J. Gane, Young-Suk Lim, Stuart C. Gordon, Kumar Visvanathan, Eric Sicard, Richard N. Fedorak, Stuart Roberts, Benedetta Massetto, Zhishen Ye, Stefan Pflanz, Kimberly L. Garrison, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shyamasundaran Kottilil, Bradley Freilich, Carla S. Coffin, Wendy Cheng, Yoon Jun Kim

JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development

Natalia Volodko, Mohamed Salla, Bertus Eksteen, Richard N. Fedorak, Hien Q. Huynh, Shairaz Baksh

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study

Maria E. Negron, Ali Rezaie, Herman W. Barkema, Kevin Rioux, Jeroen De Buck, Sylvia Checkley, Paul L. Beck, Matthew Carroll, Richard N. Fedorak, Levinus Dieleman, Remo Panaccione, Subrata Ghosh, Gilaad G. Kaplan

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy

Richard N. Fedorak, Kathleen P. Ismond

DIGESTIVE DISEASES (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples

Julia J. Liu, Theresa M. Kay, Elisabeth M. Davis, Yuefei Lou, Dina Kao, Brian Claggett, Richard N. Fedorak, Randall T. Irvin

DIGESTIVE DISEASES AND SCIENCES (2016)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Recurrent Fevers After Infliximab Therapy for Ulcerative Colitis Hemophagocytic Lymphohistiocytosis

Christopher Ma, Richard N. Fedorak, Brendan P. Halloran

GASTROENTEROLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion A. Blank, Marc Chevrier, Scott Plevy, John Popp, Freddy J. Cornillie, Milan Lukas, Silvio Danese, Paolo Gionchetti, Stephen B. Hanauer, Walter Reinisch, William J. Sandborn, Dario Sorrentino, Paul Rutgeerts

GASTROENTEROLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD

Thomas Lee, Thomas Clavel, Kirill Smirnov, Annemarie Schmidt, Ilias Lagkouvardos, Alesia Walker, Marianna Lucio, Bernhard Michalke, Philippe Schmitt-Kopplin, Richard Fedorak, Dirk Haller

GUT (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease

Krista M. Reich, Richard N. Fedorak, Karen Madsen, Karen I. Kroeker

INFLAMMATORY BOWEL DISEASES (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study

Christopher Ma, Candace L. Beilman, Vivian W. Huang, Darryl K. Fedorak, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak

INFLAMMATORY BOWEL DISEASES (2016)

添加到收藏夹

Article Endocrinology & Metabolism

Urine-based metabolomic analysis of patients with Clostridium difficile infection: a pilot study

Dina Kao, Kathleen P. Ismond, Victor Tso, Braden Millan, Naomi Hotte, Richard N. Fedorak

METABOLOMICS (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study

Christopher Ma, Candace L. Beilman, Vivian W. Huang, Darryl K. Fedorak, Karen Wong, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.